Autoantibodies may be better predictors of scleroderma prognosis than disease subgroup criteria and help to predict the disease’s likely course, a new Australian study reveals. Researchers from the Australian Scleroderma Interest Group compared the clinical manifestations and outcomes among patients with systemic sclerosis (SSc) and two SSc subgroups: SSc overlap syndrome – people who have both ...
Professor Susanna Proudman: antibodies are better predictors of SSc prognosis
By Sunalie Silva
9 Mar 2020